Literature DB >> 3011823

The structure and biosynthesis of epidermal growth factor precursor.

J Scott, S Patterson, L Rall, G I Bell, R Crawford, J Penschow, H Niall, J Coghlan.   

Abstract

The structure of mouse submaxillary gland epidermal growth factor (EGF) precursor has been deduced from complementary DNAs. The mRNA is approximately 4800 bases and predicts prepro EGF to be a protein of 1217 amino acid residues (133 X 10 Mr). EGF (53 amino acid residues) is flanked by polypeptides of 188 and 976 residues at its carboxy and amino termini, respectively. The amino terminus of the precursor contains seven cysteine-rich peptides that resemble EGF. Towards the carboxy terminus is a 20-residue hydrophobic membrane spanning domain. The mild portion of the EGF precursor shares a 33% homology with the low density lipoprotein receptor, which extends over 400 amino acid residues. These features suggest that EGF precursor could function as a membrane-bound receptor. RNA dot-blot analysis and in situ hybridization show EGF mRNA to be abundant in the submaxillary gland, kidney and incisor tooth buds. Lower EGF mRNA levels were found in the lactating breast, pancreas, small intestine, ovary, spleen, lung, pituitary and liver. In the kidney EGF mRNA was most abundant in the distal convoluted tubules. Analysis of EGF precursor biosynthesis in organ culture of the submaxillary gland and kidney showed differential processing of the precursor in the two tissues. In the submaxillary gland immunoreactive low molecular weight EGF was produced, but in the kidney the high molecular weight precursor was not processed. In the distal convoluted tubule of the kidney EGF precursor may act as a receptor that is involved in ion transport.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3011823     DOI: 10.1242/jcs.1985.supplement_3.3

Source DB:  PubMed          Journal:  J Cell Sci Suppl        ISSN: 0269-3518


  10 in total

1.  Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease.

Authors:  J Garcia de Yebenes; J Yebenes; M A Mena
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

2.  Effects of alpha1D-adrenergic receptors on shedding of biologically active EGF in freshly isolated lacrimal gland epithelial cells.

Authors:  LiLi Chen; Robin R Hodges; Chika Funaki; Driss Zoukhri; Robert J Gaivin; Dianne M Perez; Darlene A Dartt
Journal:  Am J Physiol Cell Physiol       Date:  2006-06-07       Impact factor: 4.249

3.  EGFs and ERBBs--brief history and prospects.

Authors:  David F Stern
Journal:  Semin Cell Dev Biol       Date:  2010-10-21       Impact factor: 7.727

4.  Introduction to recombinant DNA.

Authors:  J Scott
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

5.  Proprotein convertase PC7 enhances the activation of the EGF receptor pathway through processing of the EGF precursor.

Authors:  Estelle Rousselet; Suzanne Benjannet; Edwidge Marcinkiewicz; Marie-Claude Asselin; Claude Lazure; Nabil G Seidah
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

Review 6.  Hybridization histochemistry.

Authors:  J D Penschow; J Haralambidis; P E Darling; I A Darby; E M Wintour; G W Tregear; J P Coghlan
Journal:  Experientia       Date:  1987-07-15

7.  EGF and TGF-beta1 gene expression in chronically rejecting small bowel transplants.

Authors:  E A Kouwenhoven; A N Stein-Oakley; P Jablonski; R W de Bruin; N M Thomson
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

8.  Presence of EGF growth factor ligands and their effects on cultured rat conjunctival goblet cell proliferation.

Authors:  Jian Gu; Lili Chen; Marie A Shatos; J David Rios; Abha Gulati; Robin R Hodges; Darlene A Dartt
Journal:  Exp Eye Res       Date:  2007-11-17       Impact factor: 3.467

Review 9.  Epidermal growth factor, from gene organization to bedside.

Authors:  Fenghua Zeng; Raymond C Harris
Journal:  Semin Cell Dev Biol       Date:  2014-02-07       Impact factor: 7.727

10.  Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo.

Authors:  Z N Zhou; V P Sharma; B T Beaty; M Roh-Johnson; E A Peterson; N Van Rooijen; P A Kenny; H S Wiley; J S Condeelis; J E Segall
Journal:  Oncogene       Date:  2013-09-09       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.